nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers
|
Dumont, Frédéric |
|
|
140 |
C |
p. 37-44 |
artikel |
2 |
A response letter to comments on “Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016”
|
Deluche, Elise |
|
|
140 |
C |
p. 165-166 |
artikel |
3 |
Comment on: Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic
|
Bautista, Francisco |
|
|
140 |
C |
p. 158-160 |
artikel |
4 |
Drug repositioning of antiretroviral ritonavir for combinatorial therapy in glioblastoma
|
Rauschenbach, Laurèl |
|
|
140 |
C |
p. 130-139 |
artikel |
5 |
Effect of urea cream on sorafenib-associated hand–foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled study
|
Lee, Young-Sun |
|
|
140 |
C |
p. 19-27 |
artikel |
6 |
Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
|
Giesen, Nicola |
|
|
140 |
C |
p. 86-104 |
artikel |
7 |
Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer: A multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study group
|
Ditto, Antonino |
|
|
140 |
C |
p. 1-10 |
artikel |
8 |
Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model
|
Eggermont, Alexander M.M. |
|
|
140 |
C |
p. 11-18 |
artikel |
9 |
Immune scores in colorectal cancer: Where are we?
|
Malka, David |
|
|
140 |
C |
p. 105-118 |
artikel |
10 |
Impact of chemoradiotherapy on the immune-related tumour microenvironment and efficacy of anti-PD-(L)1 therapy for recurrences after chemoradiotherapy in patients with unresectable locally advanced non-small cell lung cancer
|
Shirasawa, Masayuki |
|
|
140 |
C |
p. 28-36 |
artikel |
11 |
Impact of prophylaxis choice on risk of pneumocystis pneumonia in children with cancer: A case-control study
|
Geerlinks, Ashley V. |
|
|
140 |
C |
p. 71-75 |
artikel |
12 |
Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer
|
Caffo, Orazio |
|
|
140 |
C |
p. 140-146 |
artikel |
13 |
Letter of response to comments on: Developing a risk assessment score for patients with cancer during COVID-19 pandemic: A war on two fronts
|
Indini, Alice |
|
|
140 |
C |
p. 161-162 |
artikel |
14 |
Letter to the European Dermatology Forum, the European Association of Dermato-Oncology and the European Organization for Research and Treatment of Cancer on guidelines on basal cell carcinoma
|
Testori, Alessandro A.E. |
|
|
140 |
C |
p. 151-153 |
artikel |
15 |
Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context
|
Wiesweg, Marcel |
|
|
140 |
C |
p. 76-85 |
artikel |
16 |
Malignant peritoneal cytology in endometrial cancer
|
Pinelli, Ciro |
|
|
140 |
C |
p. 147-148 |
artikel |
17 |
Malignant peritoneal cytology in endometrial cancer: Areas of unmet need for evidence
|
Matsuo, Koji |
|
|
140 |
C |
p. 149-150 |
artikel |
18 |
Mesothelioma in children and adolescents: the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) contribution
|
Orbach, Daniel |
|
|
140 |
C |
p. 63-70 |
artikel |
19 |
Prospective evaluation of the prognostic value of immune-related adverse events in patients with non-melanoma solid tumour treated with PD-1/PD-L1 inhibitors alone and in combination with radiotherapy
|
Schweizer, Claudia |
|
|
140 |
C |
p. 55-62 |
artikel |
20 |
Response to: Comment on ‘Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines’
|
Peris, Ketty |
|
|
140 |
C |
p. 154-157 |
artikel |
21 |
Survival in metastatic breast cancer in the ESME study and the ATRESS effect
|
Fink, Michael K. |
|
|
140 |
C |
p. 163-164 |
artikel |
22 |
The association of non–small cell lung cancer recurrence with allogenic blood transfusion after surgical resection: A propensity score analysis of 1,803 patients
|
Tai, Ying-Hsuan |
|
|
140 |
C |
p. 45-54 |
artikel |
23 |
The impact of ARID1A mutation on molecular characteristics in colorectal cancer
|
Tokunaga, Ryuma |
|
|
140 |
C |
p. 119-129 |
artikel |